Language Function Reorganization in Patients With Arteriovenous Malformations
Study on the Language Function Reorganization in Right CerebralHemisphere of Patients With Brain Arteriovenous Malformations Using Multimodal MRI
1 other identifier
observational
120
1 country
1
Brief Summary
Brain arteriovenous malformation (AVM) is generally considered as a congenital lesion. Its unique clinical manifestation is that when the unruptured AVM involves and destroys the language function area of the left hemisphere, the patient has almost no language disorder. This phenomenon is distinct from those of acquired diseases such as cerebral infarction and gliomas. There is a hypothesis that it might be associated with that the occurrence of AVM is earlier than period of language learning. Therefore, patients with AVMs involving language areas can be regarded as population whose language areas are congenital "knocked out" but the language functions remain normal, which provide a special model and new insights for language reorganization research. Previous studies have found that the right hemisphere plays an important role in the remodeling of language function in patients with AVMs, but the specific mechanism remains unclear. The purpose of this study is to further elaborate the role of the right cerebral hemisphere in the reorganized language network and the interhemispheric interaction mechanisms in patients with AVMs involving the language areas, using multimodal magnetic resonanceimaging and from multiple dimensions such as functional remodeling, white matter pathway remodeling, structural remodeling, etc., so as to further understand the remodeling mechanism of the Chinese language network after damage of language areas, and also to provide a theoretical basis for the protection of language function in brain network surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedStudy Start
First participant enrolled
April 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
April 17, 2026
March 1, 2026
1.7 years
April 10, 2026
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Structural MRI (sMRI) Primary Metric
Cortical thickness of bilateral language-related brain regions (measured via FreeSurfer); intergroup differences between AVM patients and healthy controls
baseline and three months after surgery
Functional MRI Secondary Metrics
Resting-state regional brain activity: Amplitude of Low Frequency Fluctuation (ALFF) and Regional Homogeneity (ReHo) Dynamic effective connectivity (DCM): Excitatory/inhibitory effective connectivity between lesioned left hemisphere and remodeled right hemisphere regions
baseline and three months after surgery
Diffusion MRI (dMRI) Primary Metrics
White matter microstructural integrity: Fractional Anisotropy (FA, DTI) and Neurite Density Index (NDI, NODDI) of language-related white matter tracts Corpus callosum diffusion metrics (FA, NDI) reflecting interhemispheric communication
baseline and three months after surgery
Secondary Outcomes (1)
Multimodal Combined & Exploratory Metrics
baseline and three months after surgery
Study Arms (2)
Healthy Control
AVM patients
Interventions
Eligibility Criteria
Healthy Control and AVM patients
You may qualify if:
- AVM located within left-hemisphere language regions
- right-handedness
- native Mandarin Chinese speakers
- age 18-60 years
- high school education or above
You may not qualify if:
- comorbid neurological or psychiatric disorders
- AVM-related intracranial hemorrhage within the past month
- prior AVM treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
No. 119 South 4th Ring West Road, Fengtai District, Beijing 100070, China
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xiaofeng Deng
Brijing Tiantan Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2026
First Posted
April 17, 2026
Study Start
April 20, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
April 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share